An Evolving Frontier – Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers, an Industry Supported Symposium at IGCS 2023

Activity Overview

Eisai welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for access to the An Evolving Frontier – Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers  Enduring Education Materials, an Industry Supported Symposium at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.

Endometrial cancer is the most common gynecologic cancer in the US, with a growing burden globally.  By 2040, endometrial cancer is projected to be the 3rd most prevalent cancer and the 4th leading cause of cancer death in women worldwide.   Understanding available and effective treatment options, and how to incorporate these treatments into clinical practice is a critical need for physicians and patients.

This symposium was developed by The GOG Foundation, Inc. in partnership with Eisai.

Target Audience

The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.

Learning Objectives

Upon completion of the activities in this series, learners will demonstrate:

  • Review the current landscape for the treatment of advanced stage or recurrent endometrial cancer.
  • Understand common adverse events associated with novel therapies and review mitigation/management strategies.
  • Adopt an evidence-based approach to implement treatment options into practice for recurrent endometrial cancer patients.
  • Understand treatment sequencing and the data regarding immune check point inhibition rechallenge.
  • Identify disparities in endometrial cancer care and patients and learn what can be done to address these issues.

Moderator


Dr. Ramez Eskander

Faculty


Dr. Anna Fagotti

Dr. Stephanie Lheureux

Agenda & Presentation Materials

An Evolving Frontier – Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers, an Industry Supported Symposium at the IGCS 2023 Annual Global Meeting

Presented on Sunday, November 5, 2023 from 12:40 – 14:10 KST

This session is not included in the main event CME/CPD credit.

How To Access The Recording

When viewing the recording, all registrants must sign in to Education360 Learning Portal with their IGCS username and password. If you receive email communications from IGCS, you already have an account.

  • If you have forgotten your password, please click here.
  • For further assistance with your IGCS account, contact igcs@igcs.org.
  • If you are unsure of your IGCS account login information, please contact igcs@igcs.org.

View Recording

12:40 – 12:45 KIST
Welcome & Introductions – View Presentation
Ramez Eskander, MD, UC San Diego Moores Comprehensive Cancer Center, USA
12:45 – 13:10 KIST
The Evolving Treatment Landscape for The Management of Endometrial Cancer – View Presentation
Ramez Eskander, MD, UC San Diego Moores Comprehensive Cancer Center, USA
13:10 – 13:35 KIST
Immunotherapy After Immunotherapy, What Are The Opportunities for Immune Check-Point Inhibition Re-challenge and The Role of Pembrolizumab/Lenvatinib – View Presentation
Stephanie Lheureux, MD, PhD, Princess Margaret Cancer Centre, Canada
13:35– 14:00 KIST
Disparities in Endometrial Cancer Outcomes, What More Can We Do? – View Presentation
Anna Fagotti, MD, PhD, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Università Cattolica del Sacro Cuore, Italy
14:00 – 14:10 KIST
Discussion & Wrap Up
All Faculty

Technical Requirements

The virtual live broadcast is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.